INTERNATIONAL PATENT: FRONTIER MEDICINES CORPORATION FILES APPLICATION FOR "POLYMORPHIC FORMS OF KRAS INHIBITORS AND USES THEREOF"

GENEVA, Oct. 1 -- FRONTIER MEDICINES CORPORATION (151 Oyster Point Blvd., 2nd FloorSouth San Francisco, California 94080) filed a patent application (PCT/US2025/020472) for "POLYMORPHIC FORMS OF KRAS INHIBITORS AND USES THEREOF" on Mar 18, 2025. With publication no. WO/2025/199170, the details related to the patent application was published on Sep 25, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): PATEL, Snahel (c/o Frontier Medicines Corporation151 Oyster Point Blvd., 2nd FloorSouth San Francisco, California 94080), XU, Jun (c/o Crystal Pharmatech Co., LtdB4-101, Biobay, 218 Xinghu Street,...